No survival benefit in Covid-19 patients receiving HCQ: Study
New York, June 6 After several studies revealed the side effects of anti-malarial drug hydroxychloroquine (HCQ), new research has found that HCQ did not reduce the risk of ventilation or death in Covid-19 patients and was associated with…